BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hong E, Terrade A, Denizon M, Aouiti-Trabelsi M, Falguières M, Taha MK, Deghmane AE. Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules. BMC Infect Dis 2021;21:715. [PMID: 34330228 DOI: 10.1186/s12879-021-06440-w] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
Number Citing Articles
1 Pillaca-pullo O, Vieira LD, Takagi M. Scale-Up of Capsular Polysaccharide Production Process by Haemophilus influenzae Type b Using kLa Criterion. Bioengineering 2022;9:415. [DOI: 10.3390/bioengineering9090415] [Reference Citation Analysis]
2 Herzberg J, Fischer B, Becher H, Becker A, Honarpisheh H, Guraya SY, Strate T, Knabbe C. Cellular and Humoral Immune Response to a Third Dose of BNT162b2 COVID-19 Vaccine – A Prospective Observational Study. Front Immunol 2022;13:896151. [DOI: 10.3389/fimmu.2022.896151] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Deghmane AE, Taha MK. Changes in Invasive Neisseria meningitidis and Haemophilus influenzae Infections in France during the COVID-19 Pandemic. Microorganisms 2022;10:907. [PMID: 35630352 DOI: 10.3390/microorganisms10050907] [Reference Citation Analysis]
4 Kanduc D. From Genetics to Epigenetics: Top 4 Aspects for Improved SARS-CoV-2 Vaccine Designs as Paradigmatic Examples. Glob Med Genet 2022;09:014-7. [DOI: 10.1055/s-0041-1739495] [Reference Citation Analysis]
5 Steens A, Stanoeva KR, Knol MJ, Mariman R, de Melker HE, van Sorge NM. Increase in invasive disease caused by Haemophilus influenzae b, the Netherlands, 2020 to 2021. Euro Surveill 2021;26. [PMID: 34676819 DOI: 10.2807/1560-7917.ES.2021.26.42.2100956] [Cited by in F6Publishing: 2] [Reference Citation Analysis]